Approval · Notice of Compliance 8578 · 2007
SANDOMIGRAN: Notice of Compliance 8578
Issued February 8, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8578
- Date
- February 8, 2007
- Company
- Squire Pharmaceuticals Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Prophylactic management of vascular headaches
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SANDOMIGRAN | 00329320 | Cancelled Post Market |
| SANDOMIGRAN DS | 00511552 | Marketed |
Medicinal ingredients
- PIZOTIFEN MALATE 0.5 MG per TAB
- PIZOTIFEN MALATE 1 MG per TAB